- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on Oct 22, 2018 at 03:01:00)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| Oct 23, 2018 | A-65-18 | APP | Sadhu Singh Hamdard Trust V. Navsun Holdings Ltd. (Trade-mark) | Toronto | 3 h |
| Oct 23, 2018 | A-94-17 | APP | Airbus Helicopters S.a.s. C. Bell Helicopter Textron Canada Ltée (Patent) | Montréal | 1 d |
| Oct 23, 2018 | T-1471-17 | M | Pfizer Canada Inc. V. Genentech, Inc. Et Al (Patent - Bevacizumab*) | Ottawa | 1 d |
| Oct 23, 2018 | T-608-17 | M | Seedlings Life Science Ventures,llc V. Pfizer Canada Inc. (Patent) | Toronto | 1 d |
| Oct 23, 2018 | T-700-16 | T | Western Driving Academy Of London Inc. V. Western City Driving School Inc. (Trade Mark) | Toronto | 2 d |
| Oct 24, 2018 | A-112-18 | APP | Mediatube Corp. Et Al V. Bell Canada (Patent) | Toronto | 1 d |
| Oct 24, 2018 | A-35-17 | APP | Mediatube Corp. V. Bell Canada (Patent) | Toronto | 1 d |
| Oct 24, 2018 | T-1396-13 | TMC | Lantech.com, Llc V. Wulftec International Inc. (Patent) | Ottawa | 1 h |
| Oct 24, 2018 | T-1969-17 | M | Genentech, Inc. Et Al. V. Celltrion Healthcare Co., Ltd. (unknown - Trastuzumab*) | Ottawa | 1 h |
| Oct 24, 2018 | T-1970-17 | M | Genentech, Inc. Et Al V. Celltrion Healthcare Co., Ltd. (unknown - Trastuzumab*) | Ottawa | 1 h |
| Oct 24, 2018 | T-1971-17 | M | Genentech, Inc. Et Al V. Celltrion Healthcare Co., Ltd (unknown - Trastuzumab*) | Ottawa | 1 h |
| Oct 24, 2018 | T-1202-16 | CMC | 002152706 Ontario Ltd Et Al V. Changer & Dresser Inc. (Patent) | Ottawa | 1 h |
| Oct 25, 2018 | T-286-13 | M | Zero Spill Systems (int'l) Inc. Et Al V. 1284897 Alberta Ltd. Et Al (Patent) | Toronto | 4 h |
| Oct 25, 2018 | T-229-18 | CMC | Varco I/p Et Al V. Coil Solutions, Inc. (Patent) | Toronto | 30 m |
| Oct 26, 2018 | T-929-18 | CMC | Galderma Canada Inc., Et Al. V. Apotex Inc. (Patent - Doxycycline*) | Ottawa | 2 h |
| Oct 26, 2018 | T-929-18 | TMC | Galderma Canada Inc., Et Al. V. Apotex Inc. (Patent - Doxycycline*) | Ottawa | 2 h |
| Oct 29, 2018 | T-1486-17 | H | Hoffmann-la Roche Limited V. Celltrion Healthcare Co. Ltd. Et Al (Patent - Rituximab*) | Ottawa | 2 h |
| Oct 29, 2018 | T-1487-17 | H | Hoffmann-la Roche Limited V. Celltrion Healthcare Co. Ltd. Et Al. (Patent - Rituximab*) | Ottawa | 2 h |
| Oct 29, 2018 | T-1488-17 | H | Hoffmann-la Roche Limited V. Celltrion Healthcare Co. Ltd. Et Al. (Patent - Rituximab*) | Ottawa | 2 h |
| Oct 29, 2018 | T-1489-17 | H | Hoffmann-la Roche Limited V. Celltrion Healthcare Co. Ltd. Et Al. (Patent - Rituximab*) | Ottawa | 2 h |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Oct 22, 2018 | T-1056-15 | Western Oilfield Equipment Rentals Ltd V. M-i Llc (Patent) | Calgary | 20 d |
| Oct 23, 2018 | T-700-16 | Western Driving Academy Of London Inc. V. Western City Driving School Inc. (Trade Mark) | Toronto | 2 d |
| Nov 5, 2018 | T-1064-13 | Apotex Inc. V. Pfizer Canada Inc. (PMNOC - Section 8 - Latanoprost*) | Toronto | 22 d |
| Nov 5, 2018 | T-393-14 | Apotex Inc. V. Pfizer Inc Et Al (Patent - Latanoprost*) | Toronto | 22 d |
| Nov 19, 2018 | T-1371-16 | Agropur Coopérative C. Parmalat Canada Inc. (Patent) | Ottawa | 10 d |
| Dec 3, 2018 | T-1396-13 | Lantech.com, Llc V. Wulftec International Inc. (Patent) | Montréal | 14 d |
| Dec 11, 2018 | T-2532-14 | 3469051 Canada Inc. C. Axis Heating And Air Conditioning Inc. (Trade Mark) | Montréal | 3 d |
| Dec 12, 2018 | T-1064-13 | Apotex Inc. V. Pfizer Canada Inc. (PMNOC - Section 8 - Latanoprost*) | Toronto | 3 d |
| Dec 12, 2018 | T-393-14 | Apotex Inc. V. Pfizer Inc Et Al (Patent - Latanoprost*) | Toronto | 3 d |
| Jan 28, 2019 | T-598-15 | Specialized Desanders Inc. V. Enercorp Sand Solution Inc. Et Al. (Patent) | Calgary | 10 d |
| Feb 4, 2019 | T-1930-13 | Tensar Technologies Ltd Et Al V. Enviro-pro Geosynthetics Ltd. (Patent) | Montréal | 10 d |
| Feb 13, 2019 | T-598-15 | Specialized Desanders Inc. V. Enercorp Sand Solution Inc. Et Al. (Patent) | Calgary | 3 d |
| Mar 11, 2019 | T-1612-16 | Aux Sable Liquid Products Lp Et Al. V. Jl Energy Transportation Inc. (Patent) | Calgary | 10 d |
| Apr 1, 2019 | T-1231-17 | Spin Master Ltd V. Mattel Canada Inc. (Patent) | Toronto | 10 d |
| May 6, 2019 | T-816-17 | Rosseau Asset Management Ltd V. The Rosseau Group Inc Et Al (Trade Mark) | Toronto | 5 d |
| May 6, 2019 | T-548-18 | Loblaws Inc. V. Columbia Insurance Company Et Al (Trade Mark) | Toronto | 5 d |
| May 21, 2019 | T-2060-14 | Painless Casing Services Ltd Et Al V. Hybrid Energy Services Ltd (Patent) | Edmonton | 7 d |
| Jul 8, 2019 | T-346-17 | Icon Elite Group Inc. V. Blue Sports Import-export Inc. Et Al (Patent) | Montréal | 5 d |
| Sep 9, 2019 | T-1969-17 | Genentech, Inc. Et Al. V. Celltrion Healthcare Co., Ltd. (unknown - Trastuzumab*) | Toronto | 10 d |
| Sep 9, 2019 | T-1970-17 | Genentech, Inc. Et Al V. Celltrion Healthcare Co., Ltd. (unknown - Trastuzumab*) | Toronto | 10 d |
| Sep 9, 2019 | T-1971-17 | Genentech, Inc. Et Al V. Celltrion Healthcare Co., Ltd (unknown - Trastuzumab*) | Toronto | 10 d |
| Sep 16, 2019 | T-633-18 | Nutramax Laboratories, Inc. V. Aventix Animal Health Corporation (Patent) | Ottawa | 5 d |
| Sep 30, 2019 | T-396-13 | Hospira Healthcare Corporation V. The Kennedy Institute Of Rheumatology (Patent - Infliximab*) | Toronto | 10 d |
| Sep 30, 2019 | T-353-18 | Janssen Inc. Et Al V. Teva Canada Limited (Patent - Paliperidone*) | Toronto | 10 d |
| Oct 21, 2019 | T-1280-14 | Marlboro Canada Limited Et Al V. Philip Morris Brands Sarl Et Al (Trade Mark) | Montréal | 20 d |
| Oct 21, 2019 | T-608-17 | Seedlings Life Science Ventures,llc V. Pfizer Canada Inc. (Patent) | Ottawa | 15 d |
| Oct 21, 2019 | T-783-17 | Palos Verdes Building Corp. V. Rozon Batteries Inc. (Trade Mark) | Ottawa | 10 d |
| Oct 28, 2019 | T-301-16 | Wi-lan Inc. V. Telus Corporation Et Al. (Patent) | Toronto | 30 d |
| Oct 28, 2019 | T-303-16 | Wi-lan Inc. V. Bell Mobility Inc. (Patent) | Toronto | 30 d |
| Oct 28, 2019 | T-304-16 | Wi-lan Inc. V. Rogers Communications Canada Inc. (Patent) | Toronto | 30 d |
| Nov 4, 2019 | T-350-18 | Bristol-myers Squibb Canada Co. Et Al V. Apotex Inc. (Patent - Apixaban*) | Toronto | 10 d |
| Nov 4, 2019 | T-351-18 | Bristol-myers Squibb Canada Co. Et Al V. Apotex Inc. (Patent - Apixaban*) | Toronto | 10 d |
| Nov 18, 2019 | T-401-18 | Hoffmann-la Roche Limited Et Al V. Pfizer Canada Inc. (Patent - Trastuzumab*) | Toronto | 10 d |
| Nov 18, 2019 | T-402-18 | Hoffmann-la Roche Limited Et Al V. Pfizer Canada Inc. (Patent - Trastuzumab*) | Toronto | 10 d |
| Jan 6, 2020 | T-1471-17 | Pfizer Canada Inc. V. Genentech, Inc. Et Al (Patent - Bevacizumab*) | Toronto | 10 d |
| Jan 13, 2020 | T-666-18 | Bayer Inc. Et Al V. Jamp Pharma Corp. (Patent - Vardenafil*) | Montréal | 10 d |
| Jan 20, 2020 | T-741-18 | Amgen Inc. Et Al V. Pfizer Canada Inc. (Patent - Pegfilgrastim*) | Toronto | 10 d |
| Jan 27, 2020 | T-823-18 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Rituximab*) | Toronto | 10 d |
| Jan 27, 2020 | T-824-18 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Rituximab*) | Toronto | 10 d |
| Jan 27, 2020 | T-825-18 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Rituximab*) | Toronto | 10 d |
| Jan 27, 2020 | T-826-18 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Rituximab*) | Toronto | 10 d |
| Feb 3, 2020 | T-546-12 | Bauer Hockey Ltd. V. Sport Maska Inc. Et Al (Patent) | Montréal | 23 d |
| Feb 10, 2020 | T-929-18 | Galderma Canada Inc., Et Al. V. Apotex Inc. (Patent - Doxycycline*) | Ottawa | 10 d |
| Feb 17, 2020 | T-2004-13 | Sanofi Et Al V. Sandoz Canada Inc. (Patent - Clopidogrel*) | Toronto | 12 d |
| Feb 17, 2020 | T-2009-13 | Sanofi Et Al V. Pharmascience Inc. Et Al (Patent - Clopidogrel*) | Toronto | 12 d |
| Feb 24, 2020 | T-229-18 | Varco I/p Et Al V. Coil Solutions, Inc. (Patent) | Toronto | 10 d |
| Mar 2, 2020 | T-1349-17 | Wi-lan, Inc. V. Lg Electronics, Inc. Et Al (Patent) | Toronto | 15 d |
| Mar 2, 2020 | T-1163-18 | Biogen Canada Inc Et Al V. Taro Pharmaceuticals Inc (Patent - FAMPRIDINE*) | Toronto | 10 d |
| Mar 16, 2020 | T-1575-18 | Bristol-myers Squibb Canada Co. Et Al V. Teva Canada Limited (Patent - Apixaban*) | Toronto | 10 d |
| Apr 20, 2020 | T-1503-18 | Amgen Inc. Et Al. V. Sandoz Canada Inc. (Patent - Pegfilgrastim*) | Toronto | 10 d |
| May 4, 2020 | T-1478-18 | Teva Canada Innovation Et Al V. Sandoz Canada Inc. (Patent - GLATIRAMER*) | Ottawa | 10 d |
| May 4, 2020 | T-1479-18 | Teva Canada Innovation Et Al V. Sandoz Et Al (Patent - GLATIRAMER*) | Ottawa | 10 d |
| May 11, 2020 | T-311-12 | Bauer Hockey Ltd. V. Sport Maska Inc. Dba Reebok-ccm Hockey (Trade Mark) | Montréal | 13 d |
| Oct 19, 2020 | T-1004-18 | Akebia Therapeutics, Inc. V. Fibrogen, Inc. (Patent) | Toronto | 12 d |
| Nov 30, 2020 | T-1184-17 | Merck Sharp & Dohme Corp.et Al V. Wyeth Llc (Patent - Pneumococcal*) | Toronto | 10 d |
| Jan 18, 2021 | T-151-16 | Angelcare Development Inc. Et Al. V. Munchkin, Inc Et Al. (Patent) | Montréal | 40 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| Nov 15, 2018 | T-1855-15 | Alexion Pharmaceuticals Inc. V. Agc - Eculizumab* | S. 18.1 Application for Judicial Review | Toronto | 2 d |
| Nov 15, 2018 | T-1596-17 | Alexion Pharmaceuticals Inc. V. Attorney General Of Canada | S. 18.1 Application for Judicial Review | Toronto | 2 d |
| Nov 26, 2018 | A-265-17 | Cmrra-sodrac Inc V. Apple Canada Inc Et Al | Statutory Appeal - Copyright Board | Toronto | 3 d |
| Nov 26, 2018 | A-267-17 | Entertainment Software Association (esa) Et Al. V. Socan, Et Al. | S.28 Copyright Board | Toronto | 3 d |
| Nov 26, 2018 | A-268-17 | Socan V. Apple Canada Inc. Et Al. | S.28 Copyright Board | Toronto | 3 d |
| Nov 26, 2018 | A-270-17 | Apple Inc. Et Al V. Socan Et Al | S.28 Copyright Board | Toronto | 3 d |
| Nov 27, 2018 | T-1746-17 | Bedessee Imports Ltd. V. Glaxosmithkline Consumer Healthcare (uk) Ip Limited | Trade Mark Expungement | Toronto | 1.3 d |
| Dec 10, 2018 | T-1728-17 | Roots Corporation V. Ym Inc. (sales) | S. 18.1 Application for Judicial Review | Toronto | 1 d |
| Feb 4, 2019 | T-834-17 | Valeant Canada Lp/valeant Canada S.e.c. V. Generic Partners Canada Inc Et Al - Metformin* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 3 d |
| Mar 20, 2019 | T-442-18 | C.c. Jentsch Cellars Inc. V. O'rourke Family Vineyards Ltd. Et Al | S. 18.1 Application for Judicial Review | Vancouver | 2 d |
| Apr 1, 2019 | T-830-17 | Allergan Pharma Co., Et.al. V. Minister Of Health Et.al. - Silodosin* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 2 d |
| Apr 29, 2019 | T-1661-17 | Janssen Inc. Et Al V. Apotex Inc. Et Al - Abiraterone* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 4 d |
| May 13, 2019 | T-1034-17 | Endo Ventures Ltd. Et Al V. Apotex Inc. Et Al - Tapentadol* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 4 d |
| May 27, 2019 | T-1670-17 | Astrazeneca Canada Inc. Et Al. V. Apotex Inc. Et Al. - Ticagrelor* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 5 d |
| May 27, 2019 | T-1672-17 | Astrazeneca Canada Inc. Et Al. V. Apotex Inc. Et Al. - Ticagrelor* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 5 d |
| Jun 3, 2019 | T-1486-17 | Hoffmann-la Roche Limited V. Celltrion Healthcare Co. Ltd. Et Al - Rituximab* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Ottawa | 15 d |
| Jun 3, 2019 | T-1487-17 | Hoffmann-la Roche Limited V. Celltrion Healthcare Co. Ltd. Et Al. - Rituximab* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Ottawa | 15 d |
| Jun 3, 2019 | T-1488-17 | Hoffmann-la Roche Limited V. Celltrion Healthcare Co. Ltd. Et Al. - Rituximab* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Ottawa | 15 d |
| Jun 3, 2019 | T-1489-17 | Hoffmann-la Roche Limited V. Celltrion Healthcare Co. Ltd. Et Al. - Rituximab* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Ottawa | 15 d |
| Sep 23, 2019 | T-1143-17 | Celgene Inc. Et Al V. Dr. Reddy's Laboratories Ltd. Et Al - Lenalidomide* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 2 d |
| Sep 23, 2019 | T-1669-17 | Celgene Inc. Et Al V. Dr. Reddy's Laboratories Ltd. Et Al - Lenalidomide* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 2 d |
| Sep 30, 2019 | T-1143-17 | Celgene Inc. Et Al V. Dr. Reddy's Laboratories Ltd. Et Al - Lenalidomide* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 4 d |
| Sep 30, 2019 | T-1669-17 | Celgene Inc. Et Al V. Dr. Reddy's Laboratories Ltd. Et Al - Lenalidomide* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 4 d |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location | Length |
| Oct 22, 2018 | A-43-18 | Arkipelago Architecture Inc. V. Enghouse Systems Ltd Et Al | Appeal (S.27 - Final) - Others [from T-1645-16 - Copyright Infringement [Actions]] | Toronto | 1 h |
| Oct 23, 2018 | A-65-18 | Sadhu Singh Hamdard Trust V. Navsun Holdings Ltd. | Appeal (S.27 - Final) - Trade-marks Act [from T-185-16 - S. 18.1 Application for Judicial Review] | Toronto | 3 h |
| Oct 23, 2018 | A-94-17 | Airbus Helicopters S.a.s. C. Bell Helicopter Textron Canada LtÉe | Appeal (S.27 - Final) - Patent Act [from T-737-08 - Patent Infringement] | Montréal | 1 d |
| Oct 24, 2018 | A-35-17 | Mediatube Corp. V. Bell Canada | Appeal (S.27 - Final) - Patent Act [from T-705-13 - Patent Infringement] | Toronto | 1 d |
| Oct 24, 2018 | A-112-18 | Mediatube Corp. Et Al V. Bell Canada | Appeal (S.27 - Interloc.) - Patent Act [from T-705-13 - Patent Infringement] | Toronto | 1 d |
| Nov 5, 2018 | A-225-18 | Progress Energy Canada Ltd V. Specialized Desanders Inc Et Al | Appeal (S.27 - Interloc.) - Patent Act | Vancouver | 3 h |
| Nov 5, 2018 | A-224-18 | Enercorp Sand Solutions Inc. V. Specialized Desanders Inc. Et Al | Appeal (S.27 - Interloc.) - Patent Act [from T-598-15 - Patent Infringement] | Vancouver | 2.98333333333333 h |
| Nov 8, 2018 | A-300-17 | Lemay CÔtÉ Architectes Inc. Et Al C. Lainco Inc. | Appeal (S.27 - Final) - Copyright Act [from T-941-13 - Copyright Infringement [Actions]] | Montréal | 1 d |
| Nov 8, 2018 | A-309-17 | Commission Scolaire Des Bois-francs Et Al. V. Lainco Inc. | Appeal (S.27 - Final) - Others [from T-941-13 - Copyright Infringement [Actions]] | Montréal | 1 d |
| Nov 8, 2018 | A-310-17 | Pluritec LtÉe V. Lainco Inc. | Appeal (S.27 - Final) - Copyright Act | Montréal | 1 d |
| Nov 19, 2018 | A-283-17 | Teva Canada Ltd V. Pfizer Canada Inc Et Al - Desvenlafaxine* | Statutory Appeal - Others [from T-1399-15 - S. 18.1 Patented Medicines (Notice of Compliance) Regulations] | Ottawa | 4 h |
| Nov 20, 2018 | A-288-17 | Apotex Inc. V. Pfizer Canada Inc. Et Al - Desvenlafaxine* | Appeal (S.27 - Final) - Others [from T-402-16 - S. 18.1 Patented Medicines (Notice of Compliance) Regulations] | Ottawa | 4 h |
| Nov 27, 2018 | T-347-18 | Igor Stukanov V. Agc | Patent - Appeal of a Decision of Commissioner | Toronto | 3 h |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.